STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The aim of the STHLM3 AS NorDCaP study is to evaluate the Stockholm3 test in an active surveillance cohort to predict upgrading on rebiopsy. The study follows a paired design, evaluating our proposed protocol for follow up men on active surveillance with Stockholm3 versus the standard protocol according to national guidelines with PSA.
Epistemonikos ID: ad2c253a94fc3774876db181cccf750f0fb9f54a
First added on: May 07, 2024